Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of L. Reuteri ATCC PTA 5289 & L. Reuteri DSM 17938 in Pregnant Women to Improve Oral Health and Reduce the Risk for Prematurity or Intrauterine Growth Retardation (IUGR)

NCT03375125 is registered in ClinicalTrials.gov with Innovacion y Desarrollo de Estrategias en Salud as lead sponsor.

NCT NCT03375125
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03375125 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of L. Reuteri ATCC PTA 5289 & L. Reuteri DSM 17938 in Pregnant Women to Improve Oral Health and Reduce the Risk for Prematurity or Intrauterine Growth Retardation (IUGR)
Lead sponsor
Innovacion y Desarrollo de Estrategias en Salud
Phase
Not applicable
Overall status
Unknown status
Start date
December 20, 2017
Completion date
December 30, 2019
Enrollment
300 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

periodontitis and pregnancy